Mark Carthy Net Worth & Insider Trades

Mark Carthy Acadia Pharmaceuticals Inc

As of August 2, 2005

What is Mark Carthy's Net Worth?

The current estimated net worth of Acadia Pharmaceuticals Inc's Mark Carthy is estimated to be about $64.41M . Mark Carthy owns about 0 unit of Acadia Pharmaceuticals Inc common stock. In the last year at Acadia Pharmaceuticals Inc, Mark Carthy has sold an estimated value of $0 worth.

What is Mark Carthy's Past Insider Trading?

Mark Carthy's largest purchase order was 586,402 units , worth over $4M on April 21, 2005. In total, Mark Carthy has made about 3 transactions over a year of their time at Acadia Pharmaceuticals Inc. Mark Carthy usually trades in August, April and June, with the busiest year in 2005. The most recent transaction was a purchase order of 0 unit , worth over $0 on August 2, 2005.

OXFORD BIOSCIENCE PARTNERS IV LP, MRNA FUND II LP, OBP MANAGEMENT IV LP, JEFFREY BARNES, MARK CARTHY, JONATHAN FLEMING, MICHAEL LYTTON, ALAN WALTON

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Mark Carthy's' Mailing Address?

  • Mailing address is 222 Berkeley Street Ste 1650 Boston MA 02116 MA

What are Acadia Pharmaceuticals Inc's Past Insider Trades?

Acadia Pharmaceuticals Inc's most recent insider trade came on May 24, 2023 by Baker Bros Advisors Lp, Lp, Julian Baker, Felix Baker, Baker Bros Advisors GP Llc and Baker Brothers Life Sciences Lp who bought 921,522 units worth $23.13M . In the last 19 years, insiders at Acadia Pharmaceuticals Inc have sold an estimated value of $126.06M and bought an estimated value of $626.93M worth of shares. Insider trading is most common in June, with the busiest year in 2013. The most active traders at the company are Uli Hacksell, CEO,  Glenn Baity, EVP AND GC,  and Stephen Davis, CEO .

ACADIA PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...